Your browser doesn't support javascript.
loading
GSDMD (Gasdermin D) Mediates Pathological Cardiac Hypertrophy and Generates a Feed-Forward Amplification Cascade via Mitochondria-STING (Stimulator of Interferon Genes) Axis.
Han, Jibo; Dai, Shanshan; Zhong, Lingfeng; Shi, Xiaowen; Fan, Xiaoxi; Zhong, Xin; Lin, Wante; Su, Lan; Lin, Shuang; Han, Bingjiang; Xu, Jianjiang; Hong, Xia; Huang, Weijian; Ye, Bozhi.
Afiliación
  • Han J; Department of Cardiology, The Second Affiliated Hospital of Jiaxing University, Zhejiang, China (J.H., X.S., B.H., J.X.).
  • Dai S; The Key Laboratory of Emergency and Disaster Medicine of Wenzhou, Department of Emergency (S.D.), The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Zhong L; Department of Cardiology and The Key Laboratory of Cardiovascular Disease of Wenzhou, the First Affiliated Hospital, Wenzhou Medical University, Zhejiang, China (L.Z., X.F., X.Z., W.L., L.S., S.L., W.H., B.Y.).
  • Shi X; Department of Cardiology, The Second Affiliated Hospital of Jiaxing University, Zhejiang, China (J.H., X.S., B.H., J.X.).
  • Fan X; Department of Cardiology and The Key Laboratory of Cardiovascular Disease of Wenzhou, the First Affiliated Hospital, Wenzhou Medical University, Zhejiang, China (L.Z., X.F., X.Z., W.L., L.S., S.L., W.H., B.Y.).
  • Zhong X; Department of Cardiology and The Key Laboratory of Cardiovascular Disease of Wenzhou, the First Affiliated Hospital, Wenzhou Medical University, Zhejiang, China (L.Z., X.F., X.Z., W.L., L.S., S.L., W.H., B.Y.).
  • Lin W; Department of Cardiology and The Key Laboratory of Cardiovascular Disease of Wenzhou, the First Affiliated Hospital, Wenzhou Medical University, Zhejiang, China (L.Z., X.F., X.Z., W.L., L.S., S.L., W.H., B.Y.).
  • Su L; Department of Cardiology and The Key Laboratory of Cardiovascular Disease of Wenzhou, the First Affiliated Hospital, Wenzhou Medical University, Zhejiang, China (L.Z., X.F., X.Z., W.L., L.S., S.L., W.H., B.Y.).
  • Lin S; Department of Cardiology and The Key Laboratory of Cardiovascular Disease of Wenzhou, the First Affiliated Hospital, Wenzhou Medical University, Zhejiang, China (L.Z., X.F., X.Z., W.L., L.S., S.L., W.H., B.Y.).
  • Han B; Department of Cardiology, The Second Affiliated Hospital of Jiaxing University, Zhejiang, China (J.H., X.S., B.H., J.X.).
  • Xu J; Department of Cardiology, The Second Affiliated Hospital of Jiaxing University, Zhejiang, China (J.H., X.S., B.H., J.X.).
  • Hong X; Department of Cardiac Care Unit (X.H.), The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Huang W; Department of Cardiology and The Key Laboratory of Cardiovascular Disease of Wenzhou, the First Affiliated Hospital, Wenzhou Medical University, Zhejiang, China (L.Z., X.F., X.Z., W.L., L.S., S.L., W.H., B.Y.).
  • Ye B; Department of Cardiology and The Key Laboratory of Cardiovascular Disease of Wenzhou, the First Affiliated Hospital, Wenzhou Medical University, Zhejiang, China (L.Z., X.F., X.Z., W.L., L.S., S.L., W.H., B.Y.).
Hypertension ; 79(11): 2505-2518, 2022 11.
Article en En | MEDLINE | ID: mdl-36065823

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferones / Cardiomegalia Límite: Animals / Humans Idioma: En Revista: Hypertension Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferones / Cardiomegalia Límite: Animals / Humans Idioma: En Revista: Hypertension Año: 2022 Tipo del documento: Article